173 related articles for article (PubMed ID: 25030871)
1. [Mesonephric hyperplasia in uterine cervix: report of two cases].
Zeng Y; Wu Y; Zhu X; Zhang S; Gu P; Zhu H; Qiu W; Yi X
Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):339-40. PubMed ID: 25030871
[No Abstract] [Full Text] [Related]
2. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
3. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
4. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].
Wu HW; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346
[No Abstract] [Full Text] [Related]
5. Combined expression of p161NK4a and p27Kip1, but not p21WAF1, differentiates endocervical from endometrial adenocarcinoma.
Abu Backer FM; Mustapha NR; Othman NH
Anal Quant Cytol Histol; 2011 Oct; 33(5):283-8. PubMed ID: 22611756
[TBL] [Abstract][Full Text] [Related]
6. Immunopathological study of mesonephric lesions of cervix uteri and vagina.
Kondi-Pafitis A; Kairi E; Kontogianni KI; Dimopoulou C; Sikiotis K; Smyrniotis V
Eur J Gynaecol Oncol; 2003; 24(2):154-6. PubMed ID: 12701967
[TBL] [Abstract][Full Text] [Related]
7. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases.
Ferry JA; Scully RE
Am J Surg Pathol; 1990 Dec; 14(12):1100-11. PubMed ID: 2252101
[TBL] [Abstract][Full Text] [Related]
8. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA
Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
[TBL] [Abstract][Full Text] [Related]
9. Mammaglobin expression in gynecologic adenocarcinomas.
Hagemann IS; Pfeifer JD; Cao D
Hum Pathol; 2013 Apr; 44(4):628-35. PubMed ID: 23084633
[TBL] [Abstract][Full Text] [Related]
10. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.
Tambouret R; Clement PB; Young RH
Am J Surg Pathol; 2003 Aug; 27(8):1080-8. PubMed ID: 12883240
[TBL] [Abstract][Full Text] [Related]
11. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations.
Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G
Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.
Nishio S; Tsuda H; Fujiyoshi N; Ota S; Ushijima K; Sasajima Y; Kasamatsu T; Kamura T; Matsubara O
Pathol Res Pract; 2009; 205(5):331-7. PubMed ID: 19167836
[TBL] [Abstract][Full Text] [Related]
13. Florid mesonephric hyperplasia of the cervix: a report of a case with review of the literature.
Ayroud Y; Gelfand MM; Ferenczy A
Int J Gynecol Pathol; 1985; 4(3):245-54. PubMed ID: 2414240
[TBL] [Abstract][Full Text] [Related]
14. Mesonephric hyperplasia of the uterine cervix: a clinicopathologic study of 51 cases.
Seidman JD; Tavassoli FA
Int J Gynecol Pathol; 1995 Oct; 14(4):293-9. PubMed ID: 8598330
[TBL] [Abstract][Full Text] [Related]
15. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.
Kenny SL; McBride HA; Jamison J; McCluggage WG
Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609
[TBL] [Abstract][Full Text] [Related]
16. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
17. Expression of p16 in post-radiotherapy cervical biopsies.
El-Bahrawy M
Histopathology; 2011 Jun; 58(7):1174-6. PubMed ID: 21707719
[No Abstract] [Full Text] [Related]
18. Mesonephric adenocarcinoma (endometrioid type) of endocervix with diffuse mesonephric hyperplasia involving cervical wall and myometrium: an unusual case report.
Menon S; Kathuria K; Deodhar K; Kerkar R
Indian J Pathol Microbiol; 2013; 56(1):51-3. PubMed ID: 23924560
[TBL] [Abstract][Full Text] [Related]
19. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation.
Ordi J; Nogales FF; Palacin A; Márquez M; Pahisa J; Vanrell JA; Cardesa A
Am J Surg Pathol; 2001 Dec; 25(12):1540-5. PubMed ID: 11717545
[TBL] [Abstract][Full Text] [Related]
20. PAX2 and cyclin D1 expression in the distinction between cervical microglandular hyperplasia and endometrial microglandular-like carcinoma: a comparison with p16, vimentin, and Ki67.
Stewart CJ; Crook ML
Int J Gynecol Pathol; 2015 Jan; 34(1):90-100. PubMed ID: 25473758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
